Metapain®
Metapain®: treatment of the first patients in the phase 3 clinical study in France.
Read moreAptys pharmaservices
The branch Aptys Pharmaservices successfully passed a regulatory inspection of Good Manufacturing Practices (GMP) by the French agency ANSM.
Read moreDevelopment Committee
Alain Eschalier, Michel Wurm, Michel Fradin and Thierry Legrier join the development committee.
Read moreDevelopment
Obtention of a 750K€ loan from BPI France Financement to support the development of Metapain®
Read moreBIO international Digital conference
F. Boutignon presents SoluDiag™ and NanoSolution™ during BIO international Digital conference.
Read more